Subclinical chikungunya virus infection during pregnancy: immune and clinical characterization in a prospective cohort
Year: 2026
Type: article
Study design: Observational Study
Abstract: Introduction Mosquito-borne viral infections are a rising global public health challenge, particularly for pregnant women. Chikungunya virus (CHIKV) infection is expanding beyond endemic regions, but maternal–fetal immune responses and pregnancy outcomes remain poorly characterized, especially for asymptomatic cases. Methods We analyzed maternal blood samples collected longitudinally from early pregnancy, with paired placental and umbilical cord tissues, and cord blood obtained at delivery, in a prospective Singapore cohort. CHIKV infection was determined by reverse transcription polymerase chain reaction (RT-PCR) and serological screening. Maternal systemic immune responses were characterized by multiplex profiling of circulating immune mediators. Antibody levels and neutralizing responses were assessed in maternal and cord blood sera, alongside clinical data on pregnancy and infant outcomes. Results and discussion Among 176 participants, three (1.7%) had laboratory evidence of CHIKV infection during pregnancy and nine (5.1%) had evidence of prior infection. No vertical transmission was detected, with undetectable CHIKV RNA and neonatal IgM levels in cord blood. Maternal and cord sera exhibited CHIKV-neutralizing activity, and a positive correlation between maternal and cord IgG titers supported transplacental transfer of IgG. In the three cases of infection during pregnancy, cytokine profiling suggested an attenuation of Th1-associated mediators while preserving factors involved in fetoplacental development. These maternal CHIKV infection cases experienced uncomplicated pregnancies, and all exposed infants were born appropriate for gestational age and achieved expected developmental milestones up to 12 months. Conclusion: Subclinical maternal CHIKV infection during pregnancy may not be associated with vertical transmission or adverse early clinical outcomes, and immune profiling suggests a potentially calibrated maternal immune response.
Source: Frontiers in Immunology
Authors: Anna X. Y. Loo(Data curation, Formal analysis, Resources, Validation, Visualization, Writing – original draft), Hannah Ee Juen Yong(Data curation, Formal analysis, Resources, Validation, Visualization, Writing – original draft), Sarah K. W. Tan(Writing – review & editing), Liang Hui Loo(Writing – review & editing), Nicholas Kim-Wah Yeo(Writing – review & editing), Eu Leong Yong(Writing – review & editing), Ka Lip Chew(Writing – review & editing), Benedict Junrong Yan(Writing – review & editing), Stacey Kiat Hong Tay(Writing – review & editing), Jiun Lee(Writing – review & editing), Evelyn C. Law(Writing – review & editing), Paul A. Tambyah(Writing – review & editing), Siew-Wai Fong(Data curation, Supervision, Writing – review & editing), Shiao-Yng Chan(Conceptualization, Funding acquisition, Supervision, Writing – review & editing), Lisa F. P. Ng(Conceptualization, Data curation, Funding acquisition, Supervision, Writing – review & editing)
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7236674272
